Reviva Pharmaceuticals Holdings, Inc. (RVPH) Tops Q1 EPS by 8c

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) reported Q1 EPS of ($0.13), $0.08 better than the analyst estimate of ($0.21).

For earnings history and earnings-related data on Reviva Pharmaceuticals Holdings, Inc. (RVPH) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• Home Depot (HD) call put ratio 1.5 calls to 1 put with a focus on September 330 puts into quarter results
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery